Awakn Life Sciences Corp (AWKN)

CSE
Currency in CAD
0.10
0.00(0.00%)
Delayed Data
AWKN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.100.12
52 wk Range
0.060.23
Key Statistics
Edit
Bid/Ask
0.08 / 0.09
Prev. Close
0.1
Open
0.11
Day's Range
0.1-0.12
52 wk Range
0.06-0.23
Volume
-
Average Volume (3m)
17.57K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AWKN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Awakn Life Sciences Corp Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisting of racemic ketamine, delivered intravenously, and manualized relapse prevention cognitive behavioural therapy (CBT) which is in phase 3 trials to treat severe Alcohol Use Disorder (AUD); AWKN-002, a novel MAT consisting of a patent pending proprietary S–ketamine oral thin film, and manualized relapse prevention CBT to treat AUD; and MDMA/Zydis, an investigational medicinal product entactogen that acts as a releaser and reuptake inhibitor of serotonin, norepinephrine, and dopamine. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD; with Graft Polymer (UK) PLC to develop chemical entity series programme for trauma-related mental health disorders; and with the University of Nottingham focusing on evaluating the company’s lead aminoindane series and its potential to enhance social cognition and pro-social behaviors. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Compare AWKN to Peers and Sector

Metrics to compare
AWKN
Peers
Sector
Relationship
P/E Ratio
−1.5x−3.1x−0.6x
PEG Ratio
−0.020.000.00
Price/Book
−2.6x0.4x2.6x
Price / LTM Sales
69.2x4.7x3.1x
Upside (Analyst Target)
-109.3%55.1%
Fair Value Upside
Unlock−13.8%9.2%Unlock

Earnings

Latest Release
Dec 31, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Awakn Life Sciences (AWKN) Stock Price Today?

The Awakn Life Sciences stock price today is 0.10

What Stock Exchange Does Awakn Life Sciences Trade On?

Awakn Life Sciences is listed and trades on the CSE stock exchange.

What Is the Stock Symbol for Awakn Life Sciences?

The stock symbol for Awakn Life Sciences is "AWKN."

What Is the Awakn Life Sciences Market Cap?

As of today, Awakn Life Sciences market cap is 3.96M.

What is Awakn Life Sciences Earnings Per Share?

The Awakn Life Sciences EPS is -0.058.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.